Neurology

Investigators recently evaluated the association between diabetes and obesity and the risk of developing amyotrophic lateral sclerosis.

Results of a recent study shed light on the long-term risk of Parkinson disease in patients with depression.

The FDA has approved new options for the treatment of presbyopia and multiple sclerosis, and issued a recall after an outbreak of listeria.

Researchers evaluated 213 patients with severe epilepsy to determine the impact of cannabidiol, a marijuana extract, on seizure manifestations.

Researchers conducted a study to better understand the association between migraine and cryptogenic ischemic stroke in young adults.

Researchers conducted a phase 2/3 randomized clinical trial to better understand the effects of a calcitonin gene-related peptide receptor antagonist for the prevention of migraine.

Findings from a new study suggest that narcolepsy could be an autoimmune disorder, and should be treated like one.

New research tracked levels of coffee consumption and how they related to the risk of developing multiple sclerosis.

Researchers have announced a possible new method of treating multiple sclerosis, which could also lead to new pharmacological options for treating the condition.

Researchers have discovered a mechanism that leads to the degradation of upper motor neurons, cells linked to the development of amyotrophic lateral sclerosis.